首页> Oncology research and treatment> Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells - Insights from Healthy Donors Compared to Gastric Cancer Patients.

Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells - Insights from Healthy Donors Compared to Gastric Cancer Patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sabine,Seiffert

第一单位： Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.

作者： Sabine,Seiffert ^[1] ; Sabine,Seiffert ^[2] ; André-René,Blaudszun ^[3] ; Benjamin,Shibru ^[4] ; Justus,Körfer ^[5] ; Ulrike,Köhl ^[6] ; Stephan,Fricke ^[1] ; Ulrich,Sack ^[1] ; Andreas,Boldt

作者单位： Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany. ^[1] Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany. ^[2] Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany. ^[3] Practice for Oncology and Hematology, Peine, Germany. ^[4] Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.;Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany. ^[5] Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.;MEDiC Campus Chemnitz of TUD Dresden University of Technology at Klinikum Chemnitz gGmbH, Chemnitz, Germany. ^[6]

关键词 Checkpoint receptors Circulating NK cells Gastric cancer